Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
Published Online: 2015-11-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Alton Kremer•Ana Molina•Begoña Mellado•Bohuslav Melichar•Corina Dutcus•Han-Joo Kim•Hilary Glen•Jacek Jassem•Jakub Zolnierek•James Larkin•Jiri Tomasek•Jose Pablo Maroto•Karen Wood•M Dror Michaelson•Robert J Motzer•Thomas E Hutson•Timothy Eisen
